Standard Chemical & Pharmaceutical Co., Ltd. (TPE:1720)
Taiwan · Delayed Price · Currency is TWD 63.10
+0.10 (0.16%)
Jun 5, 2026, 1:30 PM CST
TPE:1720 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 964.51 | 927.66 | 880.5 | 834.89 | 815.41 | 706.73 |
Depreciation & Amortization | 437.33 | 431.73 | 402.08 | 344.97 | 295.21 | 217.41 |
Other Amortization | 2.24 | 2.24 | 2.66 | 2.81 | 3.4 | 3.66 |
Loss (Gain) From Sale of Assets | 4.21 | 1.09 | 5.47 | -1.27 | 7.78 | -73.78 |
Asset Writedown & Restructuring Costs | 0.4 | 0.4 | - | - | - | 1.81 |
Loss (Gain) From Sale of Investments | -22.73 | -15.73 | 0.67 | -2.89 | -1.08 | -1.45 |
Loss (Gain) on Equity Investments | 4.98 | 4.66 | 11.36 | -41.56 | -61.37 | 6.16 |
Provision & Write-off of Bad Debts | -0.36 | -2.57 | 11.33 | -9.07 | 17.81 | 0.93 |
Other Operating Activities | 236.75 | 254.37 | 399.28 | 365.66 | 421.37 | 246.52 |
Change in Accounts Receivable | -41.48 | -43.18 | -74.28 | 18.83 | -123.1 | -42 |
Change in Inventory | 37.3 | 147.24 | -105.61 | -261.59 | -187.63 | -41.14 |
Change in Accounts Payable | 84.89 | 163.49 | -26.84 | 40.64 | -93.89 | 105.31 |
Change in Unearned Revenue | -4.56 | 4.8 | 11.78 | -0.79 | 4.88 | -56.58 |
Change in Other Net Operating Assets | 113.52 | -180.65 | 150.11 | 46.18 | 170.06 | -248.54 |
Operating Cash Flow | 1,866 | 1,767 | 1,695 | 1,337 | 1,228 | 827.03 |
Operating Cash Flow Growth | 7.58% | 4.24% | 26.82% | 8.85% | 48.46% | -10.36% |
Capital Expenditures | -453.67 | -492.87 | -596.48 | -625.7 | -1,196 | -213.48 |
Sale of Property, Plant & Equipment | 0.89 | 0.88 | 15.59 | 1.53 | 0.72 | 245.64 |
Cash Acquisitions | - | - | - | - | -24.32 | 1,028 |
Sale (Purchase) of Intangibles | -13.35 | -14.05 | -5.47 | -2.72 | -4.01 | -4.81 |
Investment in Securities | -506.59 | -542.25 | -192.35 | 159.99 | 98.66 | -209.47 |
Other Investing Activities | -10.17 | -24.88 | 7.02 | -18.6 | 44.17 | -27.23 |
Investing Cash Flow | -982.88 | -1,073 | -771.69 | -485.51 | -1,081 | 819.12 |
Short-Term Debt Issued | - | 2,151 | 1,093 | 1,978 | 2,807 | 390.21 |
Long-Term Debt Issued | - | - | - | 106.49 | 132 | 50 |
Total Debt Issued | 2,511 | 2,151 | 1,093 | 2,084 | 2,939 | 440.21 |
Short-Term Debt Repaid | - | -1,601 | -1,783 | -2,528 | -2,815 | -165.99 |
Long-Term Debt Repaid | - | -186.47 | -83.86 | -29.97 | -22.45 | -18.48 |
Total Debt Repaid | -2,258 | -1,788 | -1,866 | -2,558 | -2,837 | -184.47 |
Net Debt Issued (Repaid) | 253.25 | 363.53 | -773.86 | -473.48 | 101.57 | 255.74 |
Common Dividends Paid | -500.35 | -500.35 | -482.48 | -446.74 | -446.74 | -321.65 |
Other Financing Activities | -241.59 | -241.28 | -187.97 | -155.91 | -120.27 | -51.63 |
Financing Cash Flow | -488.7 | -378.1 | -1,444 | -1,076 | -465.44 | -117.54 |
Foreign Exchange Rate Adjustments | -2.34 | -1.94 | 4.44 | 2.47 | 13.43 | -0.4 |
Net Cash Flow | 392.29 | 313.62 | -516.62 | -222.64 | -305.01 | 1,528 |
Free Cash Flow | 1,413 | 1,274 | 1,098 | 710.83 | 31.78 | 613.56 |
Free Cash Flow Growth | 22.46% | 15.98% | 54.53% | 2136.85% | -94.82% | 7.63% |
Free Cash Flow Margin | 20.08% | 18.14% | 16.18% | 11.39% | 0.54% | 13.33% |
Free Cash Flow Per Share | 7.88 | 7.12 | 6.14 | 3.97 | 0.18 | 3.43 |
Cash Interest Paid | 8.5 | 8.5 | 15.54 | 25.52 | 18 | 7.24 |
Cash Income Tax Paid | 323.32 | 323.32 | 370.94 | 281.11 | 199.52 | 136.48 |
Levered Free Cash Flow | 795.57 | 839.04 | 598.97 | 429.13 | -125.88 | -89.85 |
Unlevered Free Cash Flow | 801.34 | 844.32 | 608.39 | 445.01 | -114.14 | -85.32 |
Change in Working Capital | 238.89 | 162.98 | -18.41 | -157.02 | -270.69 | -280.95 |